一脈陽光:中國醫學影像服務第一股今日招股 預期6月7日上市
一脈陽光(02522.HK)發佈公吿,公司擬全球發售股份1781.6萬股,中國香港發售股份178.2萬股,國際發售股份1603.4萬股;2024年5月30日至6月4日招股,預期定價日為6月5日;發售價將為每股發售股份14.60-16.80港元,每手買賣單位500股;中信證券為獨家保薦人;預期股份將於2024年6月7日開始在聯交所主板買賣。公司已訂立基石投資協議,據此,基石投資者已同意(須受若干條件的規限)按發售價認購總金額 1.21億港元可購買的有關數目發售股份。基石投資者包括卓投企業管理(香港)有限公司)(“卓投管理”,由江西贛江新區卓投企業管理有限公司(“贛江卓投”)全資擁有);聯影醫療科技香港有限公司(“聯影香港”,由聯影醫療(688271.SH)全資擁有);中國新鋭醫藥控股有限公司(“中國新鋭”,新鋭醫藥(6108.HK)的全資附屬公司)。根據弗若斯特沙利文的資料,該公司是2023年中國最大的醫學影像專科醫療集團;按醫學影像中心網點數目、設備數目、以該公司作為其主要工作場所註冊的執業影像醫生的註冊數目、日均檢查量及患者支付的費用計,公司在中國所有第三方醫學影像中心運營商中排名第一。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.